Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,902,546
-
Share change
-
+622,246
-
Total reported value
-
$149,740,869
-
Price per share
-
$10.89
-
Number of holders
-
64
-
Value change
-
+$3,137,769
-
Number of buys
-
45
-
Number of sells
-
20
Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q1 2014
As of 31 Mar 2014,
TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,902,546 shares.
The largest 10 holders included
FMR LLC, Broadfin Capital, LLC, WELLINGTON MANAGEMENT CO LLP, Novo A/S, MILLENNIUM MANAGEMENT LLC, MARXE AUSTIN W & GREENHOUSE DAVID M, JENNISON ASSOCIATES LLC, PointState Capital LP, VANGUARD GROUP INC, and BlackRock Fund Advisors.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.